Research Objective The research proposed here will support the development of NGL-101, a cell therapy for treating adult-onset leukoencephalopathy with ... restoration following spinal cord injury ...

The biological roots of Tourette disorder occur in the basal ganglia, structures deep in the brain involved in the control of ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...

glia-interneuron interactions underlying neuronal migration and synapse refinement ... genetic tools and techniques to interrogate inhibitory circuit development and function, cell type-specific omics ...

We conclude that the amplitude coupling of CA1 ripple oscillations is higher within than between hemispheres and tends to decline with shank distance. Nevertheless, our results demonstrate generally ...

In December at the American Epilepsy Society’s Annual Meeting, Neurona Therapeutics presented updated data from both the low-dose (n=5) and high-dose (n=5) cohorts of the Company’s ongoing open-label ...

Mar. 10, 2025 — Feral cats have long been suspects in killing native species reintroduced into Australian conservation areas. DNA testing of the carcasses puts ...

Despite their sparse distribution, ChIs provide the largest source of acetylcholine (ACh) to striatal cells, have a prominent level of arborization and activity, and are potent modulators of striatal ...

cohorts of the Company’s ongoing open-label Phase 1/2 clinical trial of NRTX-1001 GABAergic interneuron cell therapy in adults with drug-resistant, unilateral MTLE. The low-dose cohort ...